David GENSANNE
Fonction : Physicien Médical
Groupe : Quantif
Publications associées
- Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
Cancers (Basel) · 2023 - Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view.
Phys Med. · 2023 - ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases.
Technol Cancer Res Treat · 2023 - Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation.
Front Oncol · 2022 - Evaluation of a Dedicated Software « Elements™ Spine SRS, Brainlab® » for Target Volume Definition in the Treatment of Spinal Bone Metastases With Stereotactic Body Radiotherapy.
Front Oncol · 2022 - Characterization of positioning uncertainties in PET-CT-MR trimodality solutions for radiotherapy.
J Appl Clin Med Phys · 2022 - Evaluation of inter- and intra-fraction 6D motion for stereotactic body radiation therapy of spinal metastases: influence of treatment time.
Radiat Oncol. · 2021 - How to work together between nuclear medicine and radiotherapy departments ?
Cancer Radiother · 2020 - Interest of positron emission tomography and magnetic resonance imaging for radiotherapy planning and control.
Cancer Radiother · 2020 - Définition of target volume : when et how can the radiation oncologist use PET ?
Cancer Radiother · 2019 - Imagerie inter- et intrafractions en radiothérapie stéréotaxique extracrânienne : quelles solutions pour quelles tumeurs ? [Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?].
Cancer Radiother · 2019 - Définition of target volume: when et how can the radiation oncologist use PET?
Cancer Radiother;23(6-7) :745-752. · 2019 - Inter and intrafraction imaging during stereotactic body radiation therapy : which solutions for which tumours ?
Cancer Radiother. S1278-3218(19)30389. · 2019